Lenskart in talks for 200 million infusion from Temasek, Fidelity, eyeing $5 billion valuation
Written by: Planify
Published: 25 April 2024
Updated: 10 July 2024
1 min read
Lenskart is engaged in talks with Temasek and Fidelity for a $200 million funds infusion through a secondary share sale, The Economic Times reported citing sources.
A significant increase from its previous valuation, this move would also place Lenskart's worth at over three times that of competitor Warby Parker, the report added. A New York-based online eyewear retailer, Warby Parker went public on the NYSE in 2022 with a market cap of close to $1.55 billion.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
Address
MiQB, Plot 23, Sector 18, Maruti Industrial Development Area, Opposite VLCC corporate office, Gurugram, Haryana 122015
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
